These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25043320)

  • 1. DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.
    Arias B; Fabbri C; Serretti A; Drago A; Mitjans M; Gastó C; Catalán R; Fañanás L
    J Affect Disord; 2014 Oct; 168():91-7. PubMed ID: 25043320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.
    Okuda A; Kishi T; Okochi T; Ikeda M; Kitajima T; Tsunoka T; Okumukura T; Fukuo Y; Kinoshita Y; Kawashima K; Yamanouchi Y; Inada T; Ozaki N; Iwata N
    Neuromolecular Med; 2010 Mar; 12(1):78-85. PubMed ID: 19760522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies.
    Schosser A; Gaysina D; Cohen-Woods S; Chow PC; Martucci L; Craddock N; Farmer A; Korszun A; Gunasinghe C; Gray J; Jones L; Tozzi F; Perry J; Muglia P; Owen MJ; Craig IW; McGuffin P
    Mol Psychiatry; 2010 Aug; 15(8):844-9. PubMed ID: 19255581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence of DISC1-associated morphological changes in the hippocampus, anterior cingulate cortex, or striatum in major depressive disorder cases and healthy controls.
    Stacey D; Redlich R; Opel N; Grotegerd D; Arolt V; Kugel H; Heindel W; Baune BT; Dannlowski U
    J Affect Disord; 2014 Sep; 166():103-7. PubMed ID: 25012417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population.
    Kishi T; Okochi T; Kitajima T; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Correll CU; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1618-22. PubMed ID: 21683752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder.
    Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Jun TY; Serretti A
    J Int Med Res; 2012; 40(1):258-65. PubMed ID: 22429365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-specific association of TSNAX/DISC1 locus for schizophrenia and bipolar affective disorder in South Indian population.
    Ram Murthy A; Purushottam M; Kiran Kumar HB; ValliKiran M; Krishna N; Jayramu Sriharsha K; Janardhan Reddy YC; Ghosh S; Jain S
    J Hum Genet; 2012 Aug; 57(8):523-30. PubMed ID: 22673686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genomewide association study of citalopram response in major depressive disorder.
    Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
    Binder EB; Owens MJ; Liu W; Deveau TC; Rush AJ; Trivedi MH; Fava M; Bradley B; Ressler KJ; Nemeroff CB
    Arch Gen Psychiatry; 2010 Apr; 67(4):369-79. PubMed ID: 20368512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
    Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of NOS1AP, DISC1, DAOA, and GSK3B confers susceptibility of early-onset schizophrenia in Chinese Han population.
    Hu G; Yang C; Zhao L; Fan Y; Lv Q; Zhao J; Zhu M; Guo X; Bao C; Xu A; Jie Y; Jiang Y; Zhang C; Yu S; Wang Z; Li Z; Yi Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():187-193. PubMed ID: 29100974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic association of the DAOA gene with resting-state brain activity in major depression.
    Chen J; Xu Y; Zhang J; Liu Z; Xu C; Zhang K; Shen Y; Xu Q
    Mol Neurobiol; 2012 Oct; 46(2):361-73. PubMed ID: 22851402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments.
    Palo OM; Antila M; Silander K; Hennah W; Kilpinen H; Soronen P; Tuulio-Henriksson A; Kieseppä T; Partonen T; Lönnqvist J; Peltonen L; Paunio T
    Hum Mol Genet; 2007 Oct; 16(20):2517-28. PubMed ID: 17673452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.
    ; ;
    Am J Psychiatry; 2013 Feb; 170(2):207-17. PubMed ID: 23377640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
    Adkins DE; Clark SL; Åberg K; Hettema JM; Bukszár J; McClay JL; Souza RP; van den Oord EJ
    Transl Psychiatry; 2012 Jul; 2(7):e129. PubMed ID: 22760553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.
    Drago A; Cocchi E; Crisafulli C; Serretti A
    J Neural Transm (Vienna); 2015 Mar; 122(3):465-75. PubMed ID: 24986638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.
    Garriock HA; Tanowitz M; Kraft JB; Dang VC; Peters EJ; Jenkins GD; Reinalda MS; McGrath PJ; von Zastrow M; Slager SL; Hamilton SP
    Am J Psychiatry; 2010 May; 167(5):565-73. PubMed ID: 20194481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.